SCHEMBL25428722

SCHEMBL25428722

Fc1cc(-c2nccnc2Oc2ccc(C(F)(F)F)cc2)cc2nn[nH]c12

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 1/20 0.35
▸ PDE10A Q9Y233 3/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ CASP3 P42574 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SENP8 Q96LD8 1/20 0.34
▸ SENP7 Q9BQF6 1/20 0.34
▸ SENP6 Q9GZR1 1/20 0.34
▸ CCNB2 O95067 1/20 0.33
▸ CDK1 P06493 1/20 0.33
▸ CCNB1 P14635 1/20 0.33
▸ GSK3A P49840 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ CCNB3 Q8WWL7 1/20 0.33
▸ LTA4H P09960 1/20 0.32
▸ FFAR4 Q5NUL3 1/20 0.32
▸ KDR P35968 1/20 0.32
▸ FLT3 P36888 1/20 0.32
▸ TRPA1 O75762 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30544083 1.00 TRPV1 (0.35) TRPV1PDE10ANPC1CASP3RAB9A
SCHEMBL30544132 0.85 FEN1 (0.41) TRPV1PDE10A
SCHEMBL25429318 0.85 FEN1 (0.41) TRPV1PDE10A
SCHEMBL30544130 0.82 TRPV1 (0.37) TRPV1PDE10ACCNB2CDK1CCNB1
SCHEMBL25428892 0.82 TRPV1 (0.37) TRPV1PDE10ACCNB2CDK1CCNB1
SCHEMBL30544158 0.82 CCNB2 (0.37) TRPV1PDE10ACCNB2CDK1CCNB1
SCHEMBL25340897 0.82 CCNB2 (0.37) TRPV1PDE10ACCNB2CDK1CCNB1
SCHEMBL25951852 0.79 TRPV1 (0.41) TRPV1RAB9ATRPA1
SCHEMBL25430336 0.79 CCNB2 (0.33) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL25973903 0.78 NPC1 (0.39) TRPV1NPC1CASP3RAB9ASENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback